Shelly Xiong
- Hepatology top 0.1%
- Hepatitis C virus research 22
- Epidemiology top 0.5%
- Hepatitis B Virus Studies 23
- Liver Disease Diagnosis and Treatment 7
- Influenza Virus Research Studies 1
- Pneumocystis jirovecii pneumonia detection and treatment 1
- Infectious Diseases top 1%
- HIV/AIDS drug development and treatment 16
- Virology top 5%
-
- Click Chemistry and Applications 1
-
- Biochemical and Molecular Research 1
- Co-authors
- Carol BrosgartWilliam E. DelaneyHuiling YangJohn FryPatrick MarcellinSeng Gee LimZachary GoodmanMichael Wulfsohn
- Journals
- Journal of Hepatology (9 papers)Antimicrobial Agents and Chemotherapy (4 papers)New England Journal of Medicine (3 papers)
- Partner nations
- United StatesFranceCanada
In The Last Decade
Shelly Xiong
25 papers receiving 4.1k citations
Hit Papers
Peers
Comparison fields: 5 of 77
- Hepatology 3.8k
- Epidemiology 4.0k
- Infectious Diseases 1.0k
- Virology 107
- Immunology 70
Countries citing papers authored by Shelly Xiong
This map shows the geographic impact of Shelly Xiong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shelly Xiong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shelly Xiong more than expected).
Fields of papers citing papers by Shelly Xiong
This network shows the impact of papers produced by Shelly Xiong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shelly Xiong. The network helps show where Shelly Xiong may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Shelly Xiong, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 143 | |
| 2 | 2006 | 184 | |
| 3 | 2005 | 407 | |
| 4 | 2005 | 65 | |
| 5 | 2005 | 135 | |
| 6 | 2004 | 62 | |
| 7 | Adefovir Dipivoxil for the Treatment of Hepatitis B e Antigen–Positive Chronic Hepatitis Bbreakdown → | 2003 | 1010 |
| 8 | 2003 | 185 | |
| 9 | 2003 | 446 | |
| 10 | 2003 | 1 | |
| 11 | 2003 | 120 | |
| 12 | Adefovir Dipivoxil for the Treatment of Hepatitis B e Antigen–Negative Chronic Hepatitis Bbreakdown → | 2003 | 749 |
| 13 | 2003 | 236 | |
| 14 | 2002 | 132 | |
| 15 | 2002 | 4 | |
| 16 | 2002 | 6 | |
| 17 | 2002 | 21 | |
| 18 | 2002 | 1 | |
| 19 | 2002 | 10 | |
| 20 | 1996 | 56 |
About Shelly Xiong
Shelly Xiong is a scholar working on Hepatology, Infectious Diseases and Epidemiology, having authored 25 papers that have together received 4.2k indexed citations. Recurring topics across this work include Hepatitis B Virus Studies (23 papers), Hepatitis C virus research (22 papers), HIV/AIDS drug development and treatment (16 papers), Liver Disease Diagnosis and Treatment (7 papers), Click Chemistry and Applications (1 paper), Influenza Virus Research Studies (1 paper), Biochemical and Molecular Research (1 paper) and Pneumocystis jirovecii pneumonia detection and treatment (1 paper). The work is most often cited by research in Hepatology (3.8k citations), Epidemiology (4.0k citations) and Infectious Diseases (1.0k citations). Shelly Xiong has collaborated with scholars based in United States, France and Canada. Frequent co-authors include Carol Brosgart, William E. Delaney, Huiling Yang, John Fry, Patrick Marcellin, Seng Gee Lim, Zachary Goodman, Michael Wulfsohn, Craig S. Gibbs and Stephanos J. Hadziyannis. Their work appears in journals such as Journal of Hepatology, Antimicrobial Agents and Chemotherapy, New England Journal of Medicine, Gastroenterology and Antiviral Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.